Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial

Background Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the eff ects of retinal gene therapy with an adenoassociated viral (AAV) vector encoding REP1 (AAV.REP1) in patients with thi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	MacLaren, R, Groppe, M, Barnard, A, Cottriall, C, Tolmachova, T, Seymour, L, Reed Clark, K, During, M, Cremers, F, Black, G, Lotery, A, Downes, S, Webster, A, Seabra, M
Format:	Journal article
Veröffentlicht:	2014

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. von Maclaren, R, Groppe, M, Barnard, A, Cottriall, C, Tolmachova, T, Seymour, L, Clark, K, During, M, Cremers, F, Black, G, Lotery, A, Downes, S, Webster, A, Seabra, M

Veröffentlicht 2014

Journal article

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. von Maclaren, R, Groppe, M, Barnard, A, Cottriall, C, Tolmachova, T, Seymour, L, Clark, K, During, M, Cremers, F, Black, G, Lotery, A, Downes, S, Webster, A, Seabra, M

Ähnliche Einträge